ZEVTERA

avir pharma inc.🇨🇦 Health Canada

Approval Id: adc45c17aabdb45e
Drug Approval Canada Name: ZEVTERA
Product Name: ZEVTERA
Status: Marketed
Status Date: 2018-03-20
Original Market Date: 2018-03-20
Din: 02446685
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 08:12.06.20
Atc Original: J01DI01 CEFTOBIPROLE MEDOCARIL
Atc Name: j 01 di 01
Aig Number: 0152470001
Company Name: avir pharma inc.
Company Address: 660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4

CEFTOBIPROLE (CEFTOBIPROLE MEDOCARIL SODIUM)

500 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

adc45c17aabdb45e

Type

Standard